Cor Vasa 2008, 50(2):52-53

Dvě výročí klinických studií u srdečního selhání

Jiří Vítovec1, Jindřich ©pinar2
1 I. interní kardioangiologická klinika, Fakultní nemocnice u sv. Anny a Lékařská fakulta Masarykovy univerzity
2 Interní kardiologická klinika, Fakultní nemocnice Brno a Lékařská fakulta Masarykovy univerzity, Brno, Česká republika

Published: February 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vítovec J, ©pinar J. Dvě výročí klinických studií u srdečního selhání. Cor Vasa. 2008;50(2):52-53.
Download citation

References

  1. Withering W. An account of the foxglove, and some of its medical uses: with practical remarks on dropsy, and other diseases. Birmingham, England: M. Swinney, 1785:X,V. Go to original source...
  2. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). New Engl J Med 1987;316: 1429-35. Go to original source... Go to PubMed...
  3. Swedberg K, Kjekshus J, Snapinn S. for the CONSENSUS investigators Long-term survival in severe heart failure in patiens treated with enalapril. Eur Heart J 1999;20:136-9. Go to original source... Go to PubMed...
  4. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. J Am Med Ass 1995; 273:1450-6. Go to original source... Go to PubMed...
  5. Flather MD, Yusuf S, Kober L, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000;355:1575-81. Go to original source...
  6. ©pinar J, Janský P, Kettner J, Málek I. Doporučení pro diagnostiku a léčbu akutního srdečního selhání. Cor Vasa 2006;48:K3-K31.
  7. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. New Engl J Med 1997;336:525-33. Go to original source... Go to PubMed...
  8. Adams KF Jr., Patterson JH, Gattis WA, et al. Relationship of serum digoxin concentration to mortality and morbidity in women in the Digitalis Investigation Group trial: a retrospective analysis. J Am Coll Cardiol 2005; 46:497-504. Go to original source... Go to PubMed...
  9. Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. New Engl J Med 2002;347:1403-11. Go to original source... Go to PubMed...
  10. Packer M. End of the oldest controversy in medicine - are we ready to conclude the debate on digitalis? New Engl J Med 1997;336:575-6. Go to original source... Go to PubMed...
  11. Young JB. Whither Withering's Legacy? Digoxin's Role in Our Contemporary Pharmacopeia for Heart Failure. J Am Coll Cardiol 2005;46;505-7.
  12. ©pinar J, Hradec J, Meluzín J, a spol. Doporučení pro diagnostiku a léčbu srdečního selhání ČKS 2006. Cor Vasa 2007;49:K5-K33.
  13. Ahmed A, Rich MW, Love TE, et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 2006;27:178-86. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.